Evidence that calgranulin is produced by kidney cells and is an inhibitor of calcium oxalate crystallization

American Journal of Physiology - Renal Physiology

Volumn 275, Issue 2 44-2, 1998, Pages

  Pillay, Sokalingum N ^a   Asplin, John R ^a   Coe, Fredric L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Crystal aggregation; Crystal growth; Nephrolithiasis; S100 protein

Indexed keywords

CALCIUM OXALATE; CALGRANULIN; PROTEIN S 100;

AMINO ACID COMPOSITION; ANIMAL CELL; ARTICLE; CELL ADHESION; CONTROLLED STUDY; CRYSTALLIZATION; HUMAN; HUMAN CELL; KIDNEY CELL; KIDNEY INJURY; MOLECULAR CLONING; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; RAT; URINE;

EID: 0031847270     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1998.275.2.f255     Document Type: Article

References (47)

1. Asplin, J. R., N. S. Mandel, and F. L. Coe. Evidence for calcium phosphate supersaturation in the loop of Henle. Am. J. Physiol. 270 (Renal Fluid Electrolyte Physiol. 39): F604-F613, 1996.
2. Atmani, F., and S. Khan. Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine. Urol. Res. 23: 95-101, 1995.
3. Atmani, F., B. Lacour, T. Drueke, and M. Daudon. Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization. Urol. Res. 21: 61-66, 1993.
4. Atmani, F., J. Mizon, and S. Khan. Identification of uronic acid rich protein as urinary bikunin, the light chain of inter alpha inhibitor. Eur. J. Biochem. 236: 984-990, 1996.
5. Bennett, J., S. P. Dretler, J. Selengut, and W. H. Orme-Johnson. Identification of the calcium-binding protein calgranulin in the matrix of struvite stones. J. Endourol. 8: 95-98, 1994.
6. Bhardwaj, R., C. Zotz, J. Roth, K. Mahnke, M. Falk, G. Meinardus-Harger, and C. Sorg. The calcium-binding proteins MRP8 and MRP14 form a membrane-associated heterodimer in a subset of monocytes/macrophages present in acute but absent in chromic inflammatory lesions. Eur. J. Immunol. 22: 1891-1897, 1992.
7. Blum, H., H. Beier, and H. J. Gross. Improved silver staining of plant proteins RNA and DNA in polyacrylamide gels. Electrophoresis 8: 93-99, 1987.
8. Brandtzaeg, P. The new monoclonal antibody (Mac 387) that reacts with macrophages on paraffin sections detects the well known L1 antigen. J. Histochem. Cytochem. 36: 1203-1204, 1988.
9. Carr, R. J. Aetiology of renal calculi: micro-radiographic studies. In: Proceedings of the Renal Stone Research Symposium, Leeds April, 1968, edited by A. Hodgkinson and B. E. C. Nordin. London: Churchill, 1968, p. 123-132.
10. Chomczynski, P, and N. Sacchi. Single step-method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
11. Coe, F., J. Parks, and J. Asplin. The pathogenesis and treatment of kidney stones. N. Engl. J. Med. 327: 1141-1152, 1992.
12. Coe, F. L., and J. H. Parks. New insights into the pathophysiology and treatment of nephrolithiasis: new research venues. J. Bone Miner. Res. 12: 522-533, 1997.
13. Dianoux, A., M. Stasia, J. Gagnon, and P. Vignais. The 23-Kilodalton protein, a substrate of protein kinase C, in bovine neutrophil cytosol is a member of the S100 family. Biochemistry 31: 5898-5905, 1992.
14. Donato, R. Perspectives in S100 protein biology. Cell Calcium 12: 713-726, 1991.
15. Edgeworth, J., M. Gorman, R. Bennet, P. Freemont, and N. Hogg. Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J. Biol. Chem. 266: 7706-7713, 1991.
16. Glenney, J., M. Kindy, and L. Zokas. Isolation of a new member of the S100 protein family: anmino acid sequence, tissue, and subcellular distribution. J. Cell Biol, 108: 569-578, 1989.
17. Golden, B., P. Clohessey, G. Russell, and M. Fagerhol. Calprotectin as a marker of inflammation in cystic fibrosis. Arch. Dis. Child. 74: 136-139, 1996.
18. Hammer, H., T. Kvein, A. Glennas, and K. Melby. A longitudinal study of calprotectin as an inflammatory marker in patients with reactive arthritis. Clin. Exp. Rheumatol. 13: 59-64, 1995.
19. Hess, B., Y. Nakagawa, J. H. Parks, and F. L. Coe. Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis. Am. J. Physiol. 260 (Renal Fluid Electrolyte Physiol. 29): F569-F578, 1991.
20. Imamichi, T., I. Uchida, S. Wahl, and N. Francis. Expression and cloning of migration inhibitory factor-related protein (MRP) 8 and MRP 14 in arthritis-susceptible rats. Biochem. Biophys. Res. Commun. 194: 819-835, 1993.
21. Ito, T. Significance of macrophage and cytokines in expression of stone matrix. J. Jpn. Nephrol. Soc. 87: 865-874, 1996.
22. Johne, B., M. Fagerhol, T. Lyberg, H. Prydz, P. Brandtzaeg, C. F. Naess-Anderssen, and I. Dale. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol. Pathol. 50: 113-123, 1997.
23. Kahn, H., A. Marks, H. Thorn, and R. Baumal. Role of antibody to S100 protein in diagnostic pathology. Am. J. Clin. Pathol. 79: 341-347, 1982.
24. Khan, S. R., P. N. Shevock, and R. L. Hackett. Membrane associated crystallization of calcium oxalate in vitro. Calcif. Tissue Int. 46: 116-120, 1990.
25. Knorle, R., P. Schnierle, A. Koch, N. Buchholz, F. Hering, H. Seiler, T. Ackermann, and G. Rutihauser. Tamm-Horsfall glycoprotein: role in inhibition and promotion of renal calcium oxalate stone formation studied with Fourier-transformation infrared spectroscopy. Clin. Chem. 40: 1739-1743, 1994.
26. Kok, D. J., and S. R. Khan. Calcium oxalate nephrolithiasis,a free or fixed particle disease. Kidney Int. 46: 847-854, 1994.
27. Kumar, S., and A. Moore. Tamm-Horsfall protein-uromodulin (1950-1990). Kidney Int. 37: 1395-1401, 1990.
28. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
29. Lee, S. W., C. Tomasetto, K. Swisshelm, K. Keyomarsi, and R. Sager. Down-regulation of a member of the S100 gene family in mammary carcinoma cells and expression by azadeoxycytidine treatment. Proc. Natl. Acad. Sci. USA 89: 2504-2508, 1991.
30. Mailliard, W. S., H. T. Haigler, and D. D. Schlaepfer. Calcium-dependent binding of S100C to the N-terminal domain of annexin I. J. Biol. Chem. 271: 719-725, 1996.
31. Moore, B. W. A soluble protein characteristic of the nervous system. Biochem. Biophys. Res. Commun. 19: 739-743, 1965.
32. Murao, S., F. Collart, and E. Huberman. A protein containing the cystic fibrosis antigen is an inhibitor of protein kinases. J. Biol. Chem. 264: 8356-8360, 1989.
33. Nakagawa, Y., V. Abram, J. Parks, S. Lau, J. Kawooya, and F. L. Coe. Urine glycoprotein crystal growth inhibitors: evidence for a molecular abnormality in calcium oxalate nephrolithiasis. J. Clin. Invest. 76: 1455-1462, 1985.
34. Nozawa, R., H. Kato, T. Ito, and T. Yokoto. Identification and characterization of a differentiation antigen in human neutrophils. Blood 71: 1288-1294, 1988.
35. Robertson, W. G., M. Peacock, and B. E. C. Nordin. Calcium oxalate crystalluria and urine saturation in recurrent stone formers. J. Clin. Invest. 76: 1455-1462, 1971.
36. Robertson, W. G., M. Peacock, R. W. Marshall, D. H. Marshall, and B. E. C. Nordin. Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. N. Engl. J. Med. 294: 249-252, 1976.
37. Roth, J., F. Burwinkel, C. Van Den Bos, M. Goebeler, E. Vollmer, and C. Sorg. MRP-8 and MRP-14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood 82: 1875-1883, 1993.
38. Roth, J., S. Teigelkamp, M. Wilke, L. Grün, B. Tümmler, and C. Sorg. Complex pattern of the myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. Immunobiology 186: 304-314, 1992.
39. Stampleton, A., and R. Ryall. Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the F1 activation peptide of human prothrombin. Br. J. Urol. 75: 719, 1995.
40. Stampleton, A., R. Simpson, and R. Ryall. Crystal matrix protein is related to human prothrombin. Biochem. Biophys. Res. Commun. 195: 1199-1203, 1993.
41. Steinbeck, M., C. Naess-Anderson, E. Lingaas, I. Dale, P. Brandtzaeg, and M. Fagerhol. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 336: 763-765, 1990.
42. Umekawa, T., K. Kohri, N. Amasaki, T. Yamate, K. Yoshida, K. Yamamoto, Y. Suzuki, H. Sinihara, and T. Kurita. Sequencing of a urinary stone protein, identical to alpha-one antitrypsin, which lacks 22 amino acids. Biochem. Biophys. Res. Commun. 193: 1049-1053, 1993.
43. Umekawa, T., and T. Kurita. Calprotectin-like protein is related to soluble organic matrix in calcium oxalate urinary stone. Biochem. Mol. Biol. Int. 34: 309-313, 1994.
44. Wicki, R., I. Marenholz, D. Mischke, B. Schafer, and C. Heizmann. Characterization of the human S100A12 gene, a new member of the S100 gene cluster on chromosome 1q21. Cell Calcium 20: 459-464, 1996.
45. Worcester, E. Urinary calcium oxalate crystal growth inhibitors. J. Am. Soc. Nephrol. 5: 46-53, 1994.
46. Zimmer, D., E. Cornwall, A. Landar, and W. Song. The S100 protein family: history, function, and expression. Brain Res. Bull. 37: 417-429, 1995.
47. Zimmer, D., W. Song, and W. Zimmer. Isolation of a rat S100 alpha cDNA and distribution of its mRNA in rat tissues. Brain Res. Bull. 27: 157-162, 1991.